Desolvation behavior of indinavir sulfate ethanol and follow-up by terahertz spectroscopy.


Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
15 Aug 2019
Historique:
received: 14 03 2019
revised: 29 05 2019
accepted: 16 06 2019
pubmed: 21 6 2019
medline: 25 12 2019
entrez: 21 6 2019
Statut: ppublish

Résumé

Active pharmaceutical ingredients are composed of single-component or multicomponent crystals. Multicomponent crystals include salts, co-crystals, and solvates. Indinavir sulfate is the ethanol solvate form of indinavir that is known to deliquesce through moisture absorption. However, the detailed behavior of solvent molecules in the crystal has not been investigated. In this study, we studied the desolvation mechanism of indinavir sulfate ethanol and investigated the behavior of solvent molecules in the solid from. Indinavir sulfate ethanol contained 1.7 molecules of ethanol, 0.7 of which desolvated at room temperature. They were originally two ethanol solvent molecules; one molecule of ethanol desolvated at room temperature, and the conformation of the remaining ethanol and t-butyl groups changed in conjunction with the removal of one ethanol molecule. Desolvation could hardly be detected by powder X-ray diffraction; however, it was detected using terahertz spectroscopy. Terahertz measurement of desolvation showed a high correlation with thermogravimetry data, suggesting that desolvation could be observed non-destructively using terahertz spectroscopy. We concluded that indinavir sulfate 1 ethanol deliquesced at 60% relative humidity, and it turned into an amorphous solid after drying.

Identifiants

pubmed: 31220565
pii: S0378-5173(19)30480-6
doi: 10.1016/j.ijpharm.2019.06.037
pii:
doi:

Substances chimiques

Solvents 0
Ethanol 3K9958V90M
Indinavir 5W6YA9PKKH

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

118446

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Masataka Ito (M)

Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan.

Reiko Tokuda (R)

Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan.

Hironori Suzuki (H)

Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan.

Tomoaki Sakamoto (T)

Division of Drugs, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9510, Japan.

Katsuhide Terada (K)

Faculty of Pharmacy, Takasaki University of Health and Welfare, 60, Nakaorui-machi, Takasaki, Gunma 370-0033, Japan.

Shuji Noguchi (S)

Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan. Electronic address: shuuji.noguchi@phar.toho-u.ac.jp.

Articles similaires

Silicon Dioxide Water Hot Temperature Compressive Strength X-Ray Diffraction
Cobalt Azo Compounds Ferric Compounds Polyesters Photolysis
Molecular Dynamics Simulation Printing, Three-Dimensional Polymethyl Methacrylate Temperature Dental Materials

Classifications MeSH